Balancing Participant Engagement and Protocol Compliance

I’ve been exploring strategies to enhance participant engagement in our clinical trials while ensuring strict adherence to protocols. Recently, I implemented follow-up calls every two weeks, which has created a more personal connection. Has anyone else found effective ways to maintain this balance?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‍​‌​‌‍‌‍​⁠‌⁠‍‌‌​​⁠‌‌​‍‌​‌​‌‍‌‌‌​‍‌‌​​‍‌‍⁠​​⁠‌⁠‌⁠​‍‌​‍⁠​⁠‍​‌​‍⁠​‍​‍‌⁠⁠‌​

Follow-up calls are a great idea — like turning a single date into a full-fledged relationship! I’ve found that sending personalized texts can also help add that personal touch without overwhelming participants… Have you considered using that approach too?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍​​⁠​‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‍‍‌‍​‍‌​‌​‌​⁠​​⁠​⁠‌‍⁠‌‌⁠​‍​⁠​​‌‍‌⁠‌‍‍⁠‌⁠​‍‌​​‌‌​‌‍‌‍⁠‌‌‌‍​‌‌​‌​‍​‍‌⁠⁠‌

Implementing follow-up calls is a smart move! In my experience, sending out a short survey after the calls can help gauge participant satisfaction and engagement. Have you considered using one to gather feedback on how to improve the process further?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍​​⁠​‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‍⁠‌‌​​‌⁠​​‌⁠‌​‌‍‍‌‌‍‌‌‌‌‍‍‌‍⁠⁠‌‌​⁠‌‌​‌‌​⁠‍‌​⁠‌‌⁠​‌‌‍​⁠‌⁠‍‍‌​‌⁠​‍​‍‌⁠⁠‌

It’s great that you’re connecting with participants through calls; i’ve found that integrating a quick feedback form available right after the call boosts engagement too. It gives participants a chance to share their thoughts immediately. Have you looked into using any specific survey tools for that?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍​​⁠​‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍⁠⁠‌​​‌‌​​‍​⁠​⁠​⁠​‍‌​‍⁠‌⁠​‍‌​‌‍‌⁠​⁠‌‍‍‌‌‌‌​‌​‌⁠‌​‌​‌​‍​​⁠​‌‌​‌​​‍​‍‌⁠⁠‌